Ultime notizie per Fluor (NYSE:FLR) Azioni

Fluor

Fluor is one of the largest global providers of engineering, procurement, construction, fabrication, operations, and maintenance services. The firm serves a wide range of end markets, including oil and gas, chemicals, mining, metals, and transportation. The company's business is organized into three core segments: urban solutions, mission solutions, and energy solutions. Fluor generated $16.3 billion in revenue in 2024.

Sep,12,,2019,Santa,Clara, - ,Ca, - ,Usa,-

News

Markets

Media

Trading Ideas

ASML

LRCX

ONTO

ORLY

Il noto conduttore di &#34;Mad Money&#34; esprime pareri negativi su quattro società, offrendo però valide alternative d&#39;investimento per ciascuna.

Jim Cramer scatenato: no a questo titolo perché verrà frazionato

Earnings

Pre-Market Outlook

BIDU

SOHU

Analisi pre-market delle performance attese, utili trimestrali e potenziali movimenti capaci di influenzare i mercati globali.

Medtronic, Fluor e altre 3 azioni da tenere d&#39;occhio nella giornata di martedì

Fluor Corp

Flare - United States Dollar

Essentra PLC

Fluor Corp PRF PERPETUAL USD

Flameret Inc

Fidelity U.S. Multifactor ETF

SPDR Bloomberg Investment Grade Floating Rate ETF

Pacer Funds Pacer Pacific Asset Floating Rate High Income ETF

Fleury SA

WIIM

ATXG

BGLC

BlackSky Technology Inc. Class A Common Stock

BKSY

BYRN

CAPT

CMCO

EVEX

FTAI

IESC

INOD

KTOS

LUNR

NCRA

NVVE

ONEG

RKLB

ROMA

SATL

SHIM

TPIC

ULBI

ULCC

VATE

Shares of companies within the broader industrial sector are trading higher, possibly amid overall market strength after President Trump delayed 50% EU tariffs to July.

U.S. stocks were lower, with the Dow Jones index falling around 300 points on Friday.
Shares of Frontline plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FRO#NYSE">FRO</a>) rose during Friday's session <a href="https://www.benzinga.com/quote/FRO/earnings">following first-quarter results</a>.
The company reported revenue of $427.9 million, surpassing the $264.2 million consensus. Adjusted EPS declined to 18 cents from 62 cents a year ago, missing the consensus of 23 cents.
Frontline shares gained 3.7% to $17.81 on Friday.
Here are some other big stocks recording gains in today&#8217;s session.
<ul class="wp-block-list">
<li>Merus N.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRUS#NASDAQ">MRUS</a>) shares jumped 30% to $54.04 as the company disclosed interim clinical data as of a February 27, 2025 data cutoff from the ongoing phase 2 trial of the bispecific antibody petosemtamab in combination with pembrolizumab.</li>
<li>NANO Nuclear Energy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NNE#NASDAQ">NNE</a>) rose 24.7% to $34.40.</li>
<li>Centrus Energy Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEU#NYSE">LEU</a>) gained 23.4% to $114.98.</li>
<li>Oklo Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OKLO#NYSE">OKLO</a>) rose 23.1% to $49.03 after Wedbush raised its price target on the stock from $45 to $55 and maintained an Outperform rating.</li>
<li>Centrus Energy Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEU#NYSE">LEU</a>) gained 23.1% to $114.80.</li>
<li>Uranium Energy Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UEC#NYSE">UEC</a>) gained 19.2% to $6.15.</li>
<li>NuScale Power Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMR#NYSE">SMR</a>) shares gained 16% to $29.36.</li>
<li>NexGen Energy Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NXE#NYSE">NXE</a>) rose 11.6% to $6.07.</li>
<li>Intuit Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTU#NASDAQ">INTU</a>) gained 8.8% to $724.54 after the company reported better-than-expected third-quarter financial results and raised guidance.</li>
<li>Cameco Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCJ#NYSE">CCJ</a>) rose 8.2% to $57.13.</li>
<li>BWX Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BWXT#NYSE">BWXT</a>) gained 6.5% to $114.70.</li>
<li>Fluor Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLR#NYSE">FLR</a>) rose 5.4% to $39.61.</li>
</ul>
Now Read This: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/05/45585296/jim-cramer-says-medical-properties-trust-has-too-much-risk-likes-this-industrial-stock">Jim Cramer Says Medical Properties Trust Has &#8216;Too Much Risk,&#8217; Likes This Industrial Stock</a> </li>
</ul>
Photo via Shutterstock

Intraday Update

Movers

BWXT

INTU

MRUS

Nuveen Arizona Dividend Advantage Municipal Funds 3

OKLO

Frontline, Merus, Intuit And Other Big Stocks Moving Higher On Friday

<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.fluor.com%2F&amp;esheet=54256315&amp;newsitemid=20250519864245&amp;lan=en-US&amp;anchor=Fluor+Corporation&amp;index=1&amp;md5=e7e9a1d9adb37b80a5108bff2f79f317">Fluor Corporation</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLR#NYSE">FLR</a>) announced today that Bayer's Cell Therapy Launch Facility in Berkeley, California, has been designated the first industrial manufacturing facility in the Western United States to achieve Leadership in Energy and Environmental Design (LEED) v4 Platinum Certification. The project was also named the 2025 Facility of the Year for Social Impact - Unmet Medical Needs by the International Society for Pharmaceutical Engineering (ISPE).
&nbsp;
Bayer's Cell Therapy Launch Facility in Berkeley, California.
LEED v4 Platinum certification is the highest level of recognition for sustainable building practices and indicates that a building meets the highest standards for sustainability.
Fluor's scope of work included the engineering, procurement, construction management, commissioning, qualification and validation for the 144,000-square-foot, state-of-the-art facility. It features 30,000 square feet of cleanroom space dedicated to advancing cell therapy production for neurological degenerative disorders, cardiovascular disease and other unmet medical needs.
"Fluor and Bayer collaborated to deliver Bayer's first fully electric pharmaceutical manufacturing plant, and we met an aggressive schedule to support client and patient needs," said Richard Meserole, President of Fluor's Advanced Technologies &amp; Life Sciences business. "Fluor secured LEED v4 Platinum Certification and ISPE Facility of the Year designation through effective collaboration with our trade partners, lean construction methods, and dedication to quality."
Sustainability benefits for the facility include 52.6% energy cost savings via LED, high-efficiency lighting, heat pump and rooftop solar installation. The facility boasts 100% process water reduction, 98% onsite management of rainfall high efficiency plumbing fixtures, 65% recycled content installation, high use of sustainable materials, land use maximization and various innovation credits.
This is the second new facility built by Fluor on Bayer's Biotech campus in Berkeley. Previously, Fluor completed construction of Bayer's state-of-the-art Single Use Technology biopharmaceutical manufacturing Cell Culture Technology Center in 2021.

Fluor-Built Bayer Facility Becomes First in Western US to Earn LEED v4 Platinum for Sustainability

On CNBC's &#8220;<a href="https://www.benzinga.com/topic/mad-money-lightning-round">Mad Money Lightning Round</a>,&#8221; Jim Cramer said no to O&#8217;Reilly Automotive, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ORLY#NASDAQ">ORLY</a>). 
&#8220;You want to buy the one that's not going to stock split, which is AutoZone (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AZO#NYSE">AZO</a>),&#8221;<a href="https://www.benzinga.com/quote/ORLY/earnings"> he added.</a>
Adding support to his view, O&#8217;Reilly Automotive posted first-quarter earnings of $9.35 per share on April 23, missing market estimates of $9.94 per share. The company's quarterly sales came in at $4.14 billion versus expectations of $4.17 billion.
AutoZone has outperformed the market over the past 15 years by 10.81% on an annualized basis producing an average annual return of 22.06%. Currently, the company has a market capitalization of $62.8 billion.
See Also: <a href="https://www.benzinga.com/insights/news/25/05/45322871/heres-how-much-100-invested-in-autozone-15-years-ago-would-be-worth-today">Here&#8217;s How Much $100 Invested In AutoZone 15 Years Ago Would Be Worth Today</a>
Cramer said the last couple quarters have been weak for ASML Holding N.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASML#NASDAQ">ASML</a>). He recommended buying Lam Research Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LRCX#NASDAQ">LRCX</a>) over ASML.
Supporting his view, ASML Holding reported a first-quarter sales miss on April 16. Sequentially, revenue declined by 16.75% from €9.3 billion in the fourth quarter.
Cramer said no to Onto Innovation Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ONTO#NYSE">ONTO</a>), adding that he likes Agilent (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/A#NYSE">A</a>).
Onto Innovation issued second-quarter guidance below estimates on May 8. The company sees second-quarter adjusted EPS of $1.21-$1.35, versus market estimates of $1.50. The company expects sales of $240.00 million —$260.00 million, versus projections of $269.10 million.
The Mad Money host said no to Fluor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLR#NYSE">FLR</a>). &#8220;Engineering and construction, we're going to buy letter J, we'll buy Jacobs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/J#NYSE">J</a>),&#8221; he added.
UBS analyst Steven Fisher maintained Fluor with a buy rating on May 7 and lowered the price target from $49 to $48.
Price Action:
<ul class="wp-block-list">
<li>ASML shares fell 1.4% to settle at $758.36 on Thursday.</li>
<li>O'Reilly Automotive shares rose 3.4% to close at $1,370.13 during the session.</li>
<li>Onto Innovation shares fell 5.8% to settle at $98.04.</li>
<li>Fluor shares fell 0.5% to close at $38.53 on Thursday.</li>
</ul>
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/05/45435278/wall-streets-most-accurate-analysts-give-their-take-on-3-consumer-stocks-delivering-high-dividend-yields-7">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Consumer Stocks Delivering High-Dividend Yields</a></li>
</ul>
Image: Shutterstock

Jim Cramer Prefers AutoZone Over Rival: 'Buy The One That's Not Going To Stock Split'

<a href="https://www.nytimes.com/2025/05/09/climate/trump-draft-nuclear-executive-orders.html" title="https://www.nytimes.com/2025/05/09/climate/trump-draft-nuclear-executive-orders.html">https://www.nytimes.com/2025/05/09/climate/trump-draft-nuclear-executive-orders.html</a>

Macro Economic Events

Economics

'Draft Executive Orders Aim To Speed Construction Of Nuclear Plants; The Potential Actions Could Include Overhauling The Nuclear Regulatory Commission And Leaning On The U.S. Military To Deploy New Reactors' - NY Times

UBS analyst Steven Fisher maintains Fluor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLR#NYSE">FLR</a>) with a Buy and lowers the price target from $49 to $48.

Price Target

Analyst Ratings

UBS Maintains Buy on Fluor, Lowers Price Target to $48

President Donald Trump on Sunday announced his intention to reconstruct and reopen Alcatraz, the infamous former prison on an island in San Francisco Bay, as a functioning maximum-security facility for &#8220;America's most ruthless<a href="https://www.benzinga.com/markets/equities/25/05/45217098/trumps-big-beautiful-bill-takes-shape-gop-pushes-tax-cuts-border-wall-funding-and-deep-spending-reductions-ahead-of-memorial-day-deadline"> and violent offenders.&#8221;&nbsp;</a>
What To Know: Trump described the move as a symbol of &#8220;Law, Order, and Justice&#8221; in a post on Truth Social and suggested the prison would be significantly expanded and modernized to accommodate the most dangerous criminals.
Read Next: <a href="https://www.benzinga.com/news/management/25/05/45180224/these-ev-makers-could-shine-if-musk-leaves-tesla?utm_source=articleShare">These EV Makers Could Shine If Musk Leaves Tesla&nbsp;</a>
Alcatraz operated as a federal penitentiary from 1934 to 1963 and housed notorious criminals like Al Capone and George &#8220;Machine Gun&#8221; Kelly. The prison was closed due to high operational costs, deteriorating infrastructure and logistical challenges. 
Everything, including food, fuel and water, had to be shipped by boat, making it nearly three times more expensive to run than other federal prisons. 
John Martini, an expert on Alcatraz history who served as a park ranger on the island, <a href="https://www.sfchronicle.com/sf/article/alcatraz-trump-prison-reopen-reaction-20309745.php">told</a> the San Francisco Chronicle that it would be impossible to reopen the prison because the building is "totally inoperable," with no water or sewage, and electricity only in certain parts.
"If the discussion is to rebuild the prison building to hold people, I don't think that would be feasible," Martini said. "It would have to be torn down and rebuilt."
What's Next: Reopening Alcatraz as a federal prison would require a major federal investment, with upfront costs likely in the hundreds of millions and ongoing annual expenses far exceeding those of typical mainland prison.&nbsp;
Large-scale construction and infrastructure consultants like AECOM (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACM#NYSE">ACM</a>) and Fluor Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLR#NYSE">FLR</a>) that specialize in government infrastructure and complex restoration projects would likely be essential for rebuilding Alcatraz.&nbsp;
Private prison firms including Geo Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GEO#NYSE">GEO</a>) and CoreCivic, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CWX#NYSE">CWX</a>) could also be called upon to operate the location once restoration is complete.&nbsp;
A rebuilt Alcatraz prison would also need security, communications and surveillance solutions from providers who specialize in public safety and correctional facilities like Axon Enterprise, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AXON#NASDAQ">AXON</a>) and Motorola Solutions, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSI#NYSE">MSI</a>).&nbsp;&nbsp;
Details of the plan to reopen Alcatraz remain unclear, including proposed costs or a timeline for expanding and opening the facility. However, the Bureau of Prisons, Justice Department, FBI and Homeland Security are expected to work on the project.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/05/45194998/saudi-arabias-oil-power-play-jolts-markets-can-diamondback-and-rivals-survive-the-squeeze?utm_source=articleShare">Saudi Arabia&#8217;s Oil Power Play Jolts Markets: Can Diamondback And Rivals Survive The Squeeze?</a></li>
</ul>
Image: Shutterstock

Politics

Legal

AXON

President Trump Wants To Reopen Alcatraz: Here's What It Would Take

Truist Securities analyst Jamie Cook maintains Fluor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLR#NYSE">FLR</a>) with a Buy and raises the price target from $45 to $47.

Truist Securities Maintains Buy on Fluor, Raises Price Target to $47

Fluor Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLR#NYSE">FLR</a>) shares are trading slightly higher after the company posted mixed <a href="https://www.benzinga.com/pressreleases/25/05/b45160690/fluor-reports-first-quarter-2025-results" target="_blank" rel="noreferrer noopener">first-quarter 2025 results</a>, with key metrics surpassing some expectations.
Fluor's revenue grew 6.6% year-over-year to $3.982 billion, missing the consensus of $4.18 billion. Adjusted EPS improved to 73 cents from 47 cents a year ago, above the consensus of 50 cents.
Sales by segment: Urban Solutions $2.16 billion (+45.8% YoY), Energy Solutions $1.21 billion (-15.8% YoY), Mission Solutions $597 million (-0.67% YoY), and Others $22 million (-90% YoY).
Fluor recorded a total segment profit of $131 million, compared to $118 million a year ago. The margin expanded 13 bps to 3.3%.
The company reported a net loss from core operations of $251 million, down from earnings of $67 million a year ago.
Fluor reported $5.8 billion in new awards, down 17% year over year, with 87% reimbursable. Backlog fell 12.3% to $28.7 billion, and legacy project backlog dropped 53% to $585 million.
Adjusted EBITDA rose 76.1% year-over-year to $155 million; the margin gained 154 bps to 3.9%.
At the end of the quarter, Fluor's cash and marketable securities at the end of the year were $2.5 billion. Operating cash flow of ($286) million, down from ($111) million year over year, due to higher working capital on major projects.
Fluor accelerated first-quarter share repurchases to $142 million and is targeting $600 million in total buybacks for 2025.
Fluor is engaging with clients to address potential economic uncertainty while maintaining its 2025 guidance, which excludes specific adjustment items.
2025 Outlook reaffirmed: Flour's adjusted EBITDA is projected at $575 million to $675 million, with adjusted EPS between $2.25 and $2.75 per share versus the $2.48 consensus, assuming a 30%-35% tax rate.
FLR Price Action: Fluor shares are trading higher by 0.28% at $35.84 at publication on Friday.
Photo: Shutterstock

Guidance

Fluor Q1 Beats EPS Estimates, Reaffirms Strong 2025 Outlook

FLR stock has given up its prior gain. Flour shares were trading higher after the company reported better-than-expected Q1 adjusted EPS results and issued FY25 adjusted EPS guidance with its midpoint above estimates.

Flour shares are trading higher after the company reported better-than-expected Q1 adjusted EPS results and issued FY25 adjusted EPS guidance with its midpoint above estimates.

Fluor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLR#NYSE">FLR</a>) affirms FY2025 Adj EPS guidance from $2.25-$2.75 to $2.25-$2.75 vs $2.48 analyst estimate..

Fluor Affirms FY2025 Adj EPS Guidance of $2.25-$2.75 vs $2.48 Est

Fluor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLR#NYSE">FLR</a>) reported quarterly earnings of $0.73 per share which beat the analyst consensus estimate of $0.50 by 46 percent. This is a 55.32 percent increase over earnings of $0.47 per share from the same period last year. The company reported quarterly sales of $3.98 billion which missed the analyst consensus estimate of $4.18 billion by 4.67 percent. This is a 6.64 percent increase over sales of $3.73 billion the same period last year.

Earnings Beats

Earnings Misses

Fluor Q1 Adj. EPS $0.73 Beats $0.50 Estimate, Sales $3.98B Miss $4.18B Estimate

<h3>Companies Reporting Before The Bell</h3>
• Franklin Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BEN#NYSE">BEN</a>) is estimated to report quarterly earnings at $0.47 per share on revenue of $1.98 billion. 
• Arbor Realty Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABR#NYSE">ABR</a>) is estimated to report quarterly earnings at $0.29 per share on revenue of $79.89 million. 
• American Axle &amp; Mfg Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AXL#NYSE">AXL</a>) is expected to report quarterly earnings at $0.06 per share on revenue of $1.43 billion. 
• Liberty Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LBTYA#NASDAQ">LBTYA</a>) is expected to report quarterly loss at $0.83 per share on revenue of $1.08 billion. 
• Madison Square Garden (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSGS#NYSE">MSGS</a>) is expected to report quarterly earnings at $1.30 per share on revenue of $427.39 million. 
• United States Cellular (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USM#NYSE">USM</a>) is estimated to report quarterly earnings at $0.37 per share on revenue of $925.42 million. 
• Telephone and Data Sys (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TDS#NYSE">TDS</a>) is likely to report quarterly loss at $0.02 per share on revenue of $1.19 billion. 
• FuboTV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FUBO#NYSE">FUBO</a>) is likely to report quarterly loss at $0.03 per share on revenue of $415.45 million. 
• Terex (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TEX#NYSE">TEX</a>) is estimated to report quarterly earnings at $0.57 per share on revenue of $1.25 billion. 
• WisdomTree (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WT#NYSE">WT</a>) is projected to report quarterly earnings at $0.15 per share on revenue of $108.98 million. 
• Criteo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRTO#NASDAQ">CRTO</a>) is likely to report quarterly earnings at $0.77 per share on revenue of $260.12 million. 
• Wendy's (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WEN#NASDAQ">WEN</a>) is likely to report quarterly earnings at $0.20 per share on revenue of $526.63 million. 
• Brookfield Renewable (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BEP#NYSE">BEP</a>) is estimated to report quarterly loss at $0.40 per share on revenue of $1.70 billion. 
• Brookfield Renewable (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BEPC#NYSE">BEPC</a>) is likely to report quarterly loss at $0.25 per share on revenue of $2.16 billion. 
• SES AI (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SES#NYSE">SES</a>) is likely to report quarterly earnings at $0.26 per share on revenue of $351.00 million. 
• Fulgent Genetics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLGT#NASDAQ">FLGT</a>) is projected to report quarterly loss at $0.18 per share on revenue of $71.26 million. 
• Perella Weinberg (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PWP#NASDAQ">PWP</a>) is projected to report quarterly earnings at $0.21 per share on revenue of $205.52 million. 
• Fluor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLR#NYSE">FLR</a>) is likely to report quarterly earnings at $0.50 per share on revenue of $4.18 billion. 
• Brookfield Bus Partners (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBU#NYSE">BBU</a>) is expected to report earnings for its first quarter. 
• Atmus Filtration Techs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATMU#NYSE">ATMU</a>) is likely to report quarterly earnings at $0.59 per share on revenue of $421.40 million. 
• nVent Electric (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVT#NYSE">NVT</a>) is expected to report quarterly earnings at $0.66 per share on revenue of $790.29 million. 
• Cinemark Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNK#NYSE">CNK</a>) is projected to report quarterly loss at $0.25 per share on revenue of $522.45 million. 
• Westlake Chemical (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLKP#NYSE">WLKP</a>) is expected to report quarterly earnings at $0.38 per share on revenue of $295.59 million. 
• Xenia Hotels &amp; Resorts (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XHR#NYSE">XHR</a>) is likely to report quarterly earnings at $0.42 per share on revenue of $273.46 million. 
• AirSculpt Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIRS#NASDAQ">AIRS</a>) is estimated to report quarterly loss at $0.03 per share on revenue of $39.25 million. 
• City Office REIT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIO#NYSE">CIO</a>) is expected to report quarterly earnings at $0.28 per share on revenue of $42.20 million. 
• Johnson Outdoors (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JOUT#NASDAQ">JOUT</a>) is expected to report quarterly earnings at $0.21 per share on revenue of $168.05 million. 
• AES (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AES#NYSE">AES</a>) is estimated to report quarterly earnings at $0.46 per share on revenue of $3.10 billion. 
• Patria Investments (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PAX#NASDAQ">PAX</a>) is projected to report quarterly earnings at $0.25 per share on revenue of $85.63 million. 
• Cboe Global Markets (BATS:<a class="ticker" href="https://www.benzinga.com/stock/CBOE#BATS">CBOE</a>) is likely to report quarterly earnings at $2.36 per share on revenue of $559.99 million. 
• T. Rowe Price Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TROW#NASDAQ">TROW</a>) is projected to report quarterly earnings at $2.13 per share on revenue of $1.78 billion. 
• Eaton Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ETN#NYSE">ETN</a>) is estimated to report quarterly earnings at $2.71 per share on revenue of $6.25 billion. 
• Apollo Global Management (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APO#NYSE">APO</a>) is projected to report quarterly earnings at $1.96 per share on revenue of $4.64 billion. 
• Westlake (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLK#NYSE">WLK</a>) is projected to report quarterly earnings at $0.65 per share on revenue of $2.95 billion. 
• Chevron (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVX#NYSE">CVX</a>) is likely to report quarterly earnings at $2.18 per share on revenue of $48.08 billion. 
• MISTRAS Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MG#NYSE">MG</a>) is projected to report quarterly earnings at $0.90 per share on revenue of $9.68 billion. 
• ING Groep (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ING#NYSE">ING</a>) is estimated to report earnings for its first quarter. 
• Shell (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHEL#NYSE">SHEL</a>) is expected to report quarterly earnings at $1.65 per share on revenue of $79.13 billion. 
• IES Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IESC#NASDAQ">IESC</a>) is projected to report earnings for its second quarter. 
• Magna International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MGA#NYSE">MGA</a>) is likely to report quarterly earnings at $0.86 per share on revenue of $9.73 billion. 
• Piper Sandler (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PIPR#NYSE">PIPR</a>) is likely to report quarterly earnings at $2.85 per share on revenue of $367.73 million. 
• Proto Labs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRLB#NYSE">PRLB</a>) is likely to report quarterly earnings at $0.29 per share on revenue of $123.71 million. 
• Cigna Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CI#NYSE">CI</a>) is estimated to report quarterly earnings at $6.35 per share on revenue of $60.39 billion. 
• BrightSpring Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTSG#NASDAQ">BTSG</a>) is estimated to report quarterly earnings at $0.09 per share on revenue of $2.74 billion. 
• Amneal Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMRX#NASDAQ">AMRX</a>) is estimated to report quarterly earnings at $0.15 per share on revenue of $715.49 million. 
• DuPont de Nemours (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DD#NYSE">DD</a>) is projected to report quarterly earnings at $0.95 per share on revenue of $3.04 billion. 
• inTest (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/INTT#AMEX">INTT</a>) is likely to report quarterly loss at $0.10 per share on revenue of $28.07 million. 
• Butterfly Network (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BFLY#NYSE">BFLY</a>) is projected to report quarterly loss at $0.07 per share on revenue of $21.16 million. 
• Interface (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TILE#NASDAQ">TILE</a>) is estimated to report quarterly earnings at $0.21 per share on revenue of $297.11 million. 
• Vince Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VNCE#NYSE">VNCE</a>) is projected to report quarterly loss at $0.09 per share on revenue of $72.98 million. 
• NatWest Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NWG#NYSE">NWG</a>) is expected to report earnings for its first quarter. 
• AdvanSix (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASIX#NYSE">ASIX</a>) is projected to report quarterly earnings at $0.82 per share on revenue of $347.25 million. 
• Exxon Mobil (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XOM#NYSE">XOM</a>) is expected to report quarterly earnings at $1.70 per share on revenue of $86.09 billion. 
• Brookfield Business (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBUC#NYSE">BBUC</a>) is estimated to report earnings for its first quarter. 
<h3>Companies Reporting After The Bell</h3>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AIRS

AMRX

ASIX

ATMU

BBUC

BEPC

BFLY

BTSG

CBOE

CRTO

FLGT

FUBO

INTT

JOUT

LBTYA

MSGS

PIPR

PRLB

PowerShares Exchange Traded Fund Trust Dynamic Mid Cap Value Portfolio

SHEL

TILE

TROW

VNCE

WLKP

Earnings Scheduled For May 2, 2025

Fluor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLR#NYSE">FLR</a>) is preparing to release its quarterly earnings on Friday, 2025-05-02. Here's a brief overview of what investors should keep in mind before the announcement.
Analysts expect Fluor to report an earnings per share (EPS) of $0.67.
The market awaits Fluor's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
<h3>Earnings Track Record</h3>
In the previous earnings release, the company missed EPS by $0.29, leading to a 0.55% drop in the share price the following trading session.
Here's a look at Fluor's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.77</td>
<td>0.76</td>
<td>0.68</td>
<td>0.54</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.48</td>
<td>0.51</td>
<td>0.85</td>
<td>0.47</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-1.0%</td>
<td>-14.000000000000002%</td>
<td>0.0%</td>
<td>-6.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1746108133_0.png" alt="eps graph" />
<h3>Fluor Share Price Analysis</h3>
Shares of Fluor were trading at $34.89 as of April 30. Over the last 52-week period, shares are down 7.22%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. 
<h3>Analyst Opinions on Fluor</h3>
For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Fluor.
The consensus rating for Fluor is Buy, derived from 9 analyst ratings. An average one-year price target of $47.22 implies a potential 35.34% upside.
<h3>Comparing Ratings with Peers</h3>
This comparison focuses on the analyst ratings and average 1-year price targets of Valmont Industries, Dycom Industries and WillScot Holdings, three major players in the industry, shedding light on their relative performance expectations and market positioning.
<ul>
<li>Analysts currently favor an Buy trajectory for Valmont Industries, with an average 1-year price target of $373.25, suggesting a potential 969.79% upside.</li>
<li>Analysts currently favor an Outperform trajectory for Dycom Industries, with an average 1-year price target of $199.83, suggesting a potential 472.74% upside.</li>
<li>Analysts currently favor an Neutral trajectory for WillScot Holdings, with an average 1-year price target of $35.5, suggesting a potential 1.75% upside.</li>
</ul>
<h3>Peer Analysis Summary</h3>
The peer analysis summary presents essential metrics for Valmont Industries, Dycom Industries and WillScot Holdings, unveiling their respective standings within the industry and providing valuable insights into their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Fluor</td>
<td>Buy</td>
<td>11.52%</td>
<td>$208M</td>
<td>60.10%</td>
</tr>
<tr>
<td>Valmont Industries</td>
<td>Buy</td>
<td>-6.55%</td>
<td>$313.02M</td>
<td>5.49%</td>
</tr>
<tr>
<td>Dycom Industries</td>
<td>Outperform</td>
<td>13.87%</td>
<td>$196.58M</td>
<td>2.64%</td>
</tr>
<tr>
<td>WillScot Holdings</td>
<td>Neutral</td>
<td>-1.61%</td>
<td>$336.35M</td>
<td>8.61%</td>
</tr>
</tbody>
</table>

Key Takeaway:
Fluor ranks highest in Gross Profit and Return on Equity among its peers. It ranks second in Revenue Growth.
<h3>Get to Know Fluor Better</h3>
Fluor is one of the largest global providers of engineering, procurement, construction, fabrication, operations, and maintenance services. The firm serves a wide range of end markets including oil and gas, chemicals, mining, metals, and transportation. The company's business is organized into three core segments: urban solutions, mission solutions, and energy solutions. Fluor generated $16.3 billion in revenue in 2024.
<h3>Understanding the Numbers: Fluor's Finances</h3>
Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.
Positive Revenue Trend: Examining Fluor's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 11.52% as of 31 December, 2024, showcasing a substantial increase in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Industrials sector.
Net Margin: Fluor's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 43.73%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Fluor's ROE excels beyond industry benchmarks, reaching 60.1%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): Fluor's ROA stands out, surpassing industry averages. With an impressive ROA of 22.94%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: Fluor's debt-to-equity ratio is below the industry average at 0.28, reflecting a lower dependency on debt financing and a more conservative financial approach.
<a href="https://www.benzinga.com/quote/FLR/earnings">To track all earnings releases for Fluor visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Uncovering Potential: Fluor's Earnings Preview

Citigroup analyst Andrew Kaplowitz maintains Fluor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLR#NYSE">FLR</a>) with a Buy and lowers the price target from $55 to $46.

Citigroup Maintains Buy on Fluor, Lowers Price Target to $46

U.S. stock futures were higher this morning, with the Nasdaq futures gaining around 50 points on Friday.
Shares of Skechers U.S.A., Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SKX#NYSE">SKX</a>) fell sharply in today's pre-market trading following a <a href="https://in.benzinga.com/news/earnings/25/04/44996051/skechers-stock-falls-on-q1-revenue-miss-details">first-quarter revenue miss</a>.
Skechers reported quarterly earnings of $1.34 per share, which beat the analyst consensus estimate of $1.17. Quarterly revenue came in at $2.41 billion, which missed the consensus estimate of $2.43 billion.
Skechers shares dipped 7.2% to $46.82 in the pre-market trading session.
Here are some other stocks moving lower in pre-market trading.
<ul>
<li>TMC the metals company Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TMC#NASDAQ">TMC</a>) dipped 7.3% to $3.42 in pre-market trading.</li>
<li>Azul S.A. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AZUL#NYSE">AZUL</a>) fell 7.1% to $1.05 in pre-market trading.</li>
<li>Celestica Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLS#NYSE">CLS</a>) declined 5.9% to $86.70 in pre-market trading after the company issued second-quarter sales guidance below estimates.</li>
<li>Intel Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>) fell 5.7% to $20.27 in pre-market trading. Intel reported upbeat first-quarter financial results, but issued weak outlook for the second quarter. Intel said it expects second-quarter revenue to be in the range of $11.2 billion to $12.4 billion versus estimates of $12.84 billion. The company anticipates a second-quarter earnings loss of 32 cents per share versus estimates for a loss of 16 cents per share.</li>
<li>T-Mobile US, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TMUS#NASDAQ">TMUS</a>) declined 5.5% to $247.83 in pre-market trading following first-quarter results.</li>
<li>Kingsoft Cloud Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KC#NASDAQ">KC</a>) dipped 4.7% to $11.95 in pre-market trading.</li>
<li>Gilead Sciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GILD#NASDAQ">GILD</a>) fell 3.8% to $102.14 in today's pre-market trading after the company posted mixed first-quarter results. Gilead Sciences also lowered its fiscal 2025 earnings guidance from a range of $5.95 to $6.35 per share to a range of $5.65 to $6.05 per share, versus the $6.21 estimate.</li>
<li>Fluor Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLR#NYSE">FLR</a>) slipped 3.8% to $34.24 in pre-market trading.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/25/04/45001899/alphabet-intel-and-3-stocks-to-watch-heading-into-friday">Alphabet, Intel And 3 Stocks To Watch Heading Into Friday</a> </li>
</ul>
Photo via Shutterstock

AZUL

GILD

INTC

TMUS

Skechers Posts Weak Revenue, Joins Intel, Gilead Sciences And Other Big Stocks Moving Lower In Friday's Pre-Market Session

UBS analyst Steven Fisher maintains Fluor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLR#NYSE">FLR</a>) with a Buy and lowers the price target from $57 to $49.

UBS Maintains Buy on Fluor, Lowers Price Target to $49

ARRY

AZEK

Embraer-Empresa Brasileira De Aeronautica

EVTL

HAYW

JBHT

LDOS

MATX

ODFL

PCAR

SAIA

TREX

UHAL

Shares of companies in the broader industrial sector are trading higher amid overall market strength after President Trump said he had no intention of firing Fed Chair Powell. Additionally, Trump indicated the final tariff rate would be less than the current 145% but not 0%.

AIRT

CARR

HLGN

NRGV

SHLS

Shares of companies in the broader industrial sector are trading higher following US Treasury Secretary Scott Bessent's reported remarks about trade de-escalation with China.

Press Releases

Fluor-Led JV Supports Successful Completion and Startup of Major Project at Tengiz Oil Field in Kazakhstan

Fluor to Host Strategy Update Event on April 2

Fluor Names Tracey Cook Chief Human Resources Officer

Fluor Selected for State Highway 6 Project in College Station, Texas

Fluor to Provide EPCM Services for a Second Multi-Billion-Dollar Pharmaceutical Facility in Indiana

Fluor Corporation to Hold First Quarter Earnings Conference Call

HPE Appoints Stacy Dillow as Chief People Officer

Fluor to Participate in Upcoming Investor Conferences

Fluor Reports First Quarter 2025 Results

Fluor-Built Pharmaceutical Facility in California is First Industrial Manufacturing Facility in Western United States to Achieve LEED v4 Platinum Certification

Arcosa

AECOM

Argan

Ameresco

APi Group

Bowman Consulting Group Ltd. - Common Stock

Bowman Consulting Group

Cadeler A/S American Depositary Share (each representing four (4) Ordinary Shares)

Comments

Fluor

Notizie

Ultime notizie per Fluor (NYSE:FLR) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO